MICHELLE DURM: Open Payments
NPI 1518451814 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,134 in 88 payments from 17 companies in 2025. Trend: 2023 $2,517 · 2024 $5,259 · 2025 $4,134
Food & beverage: $1,961Consulting: $1,155Speaker / faculty: $840Education: $178
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $2,212 |
| Galderma Laboratories, L.P. | 15 | $356 |
| UCB, Inc. | 16 | $314 |
| ABBVIE INC. | 12 | $280 |
| Janssen Biotech, Inc. | 5 | $223 |
| Regeneron Healthcare Solutions, Inc. | 6 | $192 |
| Arcutis Biotherapeutics, Inc. | 2 | $183 |
| Mallinckrodt Hospital Products Inc. | 2 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Amgen Inc. | 2 | $36 |
Products named: Sotyktu, NEMLUVIO, Bimzelx, TREMFYA, RINVOQ, Zoryve, DUPIXENT, ACTHAR.
Industry payments across IN — which companies pay providers there.
